NEUROLITE®
Kit for the preparation of technetium (99mTc) Disicate injection (Distributed on behalf of Lantheus Molecular Imaging)
| Isotope | Technetium (99mTc) |
| Number of radiolabelled preparations | 1 |
| Each vial contains : Vial A: Bicisate dihydrochloride Stannous Chloride dihydrate Disodium edetate, Mannitol Hydrochloric acid Nitrogen (headspace) Vial B: Disodium phosphate heptahydrate (Na2HPO42O) Sodium dihydrogen phosphate monohydrate (NaH2PO4 • 1H2O) Water for injection |
900 µg 72 µg |
| Volume of 99mpertechnetate | 740 MBq (20 mCi) in 2 ml |
| Radiochemical purity | > 90 % |
| Storage | 18 months at 25°C |
| Activity per vial | 1230 MBq (33 mCi) |
| Indications / Posology | Evaluation of regional cerebral perfusion abnormalities in adult patients with central nervous system disorders. Recommended dose is 740 MBq for a patient (70 kg) |
| Stability of labelled product | 8 hours below 258°C |
| Time between injection and examination | 6 hours |
| Availability | From stock |
Support Solution
IBA does not provide pharmaceuticals... we do much more than that. Beyond the quality of our products and services you expect a leading radiopharmaceutical company to provide you with all the environment necessary to master our products and to operate your daily activity in a professional manner.
Our set of customer solutions includes :
- Product trainings
- Round tables facilitation
- Patient recruitment support
- ISS (Investigator Sponsored Studies)
- Organisations of symposiums
- Newsletters
